US FDA approves injectable version of Roche's multiple sclerosis therapy-December 2024-www.financetom.com

US FDA approves injectable version of Roche's multiple sclerosis therapy

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves injectable version of Roche's multiple sclerosis therapy

Sep 13, 2024 2:06 PM

Sept 12 (Reuters) - The U.S. Food and Drug

Administration on Thursday approved Roche's

under-the-skin injection to treat patients with multiple

sclerosis.

(Reporting by Urvi Dugar; Editing by Subhranshu Sahu)

Previous page： FirstEnergy misses first-quarter profit estimates on unfavorable weather Next page： Ingersoll Rand Keeps Dividend Steady, Ups Share Repurchase Authorization

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

FirstEnergy misses first-quarter profit estimates on unfavorable weather

Apr 25, 2024

April 25 (Reuters) - Utility firm FirstEnergy ( FE ) missed first-quarter profit estimates on Thursday on account of unfavorable weather and higher interest expense. Milder-than-usual winter in the areas where FirstEnergy ( FE ) operates dragged down customers' need for electricity to keep themselves warm during the colder months. While heating degree days were 5% higher than the historically...

Ingersoll Rand Keeps Dividend Steady, Ups Share Repurchase Authorization

Apr 25, 2024

05:21 PM EDT, 04/25/2024 (MT Newswires) -- Ingersoll Rand ( IR ) said late Thursday it kept its quarterly dividend steady at $0.02 a share, payable June 6 to shareholders of record May 16. The company also said its board approved an incremental $1 billion increase to its share repurchase authorization, adding that it will fully utilize the remainder of...

Erie Indemnity Q1 Earnings, Revenue Rise

Apr 25, 2024

05:18 PM EDT, 04/25/2024 (MT Newswires) -- Erie Indemnity ( ERIE ) reported Q1 earnings late Thursday of $2.38 per diluted share, up from $1.65 a year earlier. One analyst surveyed by Capital IQ expected $2.33. Operating revenue for the quarter ended March 31 was $880.7 million, up from $752.5 million a year earlier. One analyst surveyed by Capital IQ...

Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing

Apr 25, 2024

05:16 PM EDT, 04/25/2024 (MT Newswires) -- Felicia F Norwood, Executive Vice President & President, Government Health Benefits, on April 23, 2024, sold 20,310 shares in Elevance Health ( ELV ) for $10,832,155. Following the Form 4 filing with the SEC, Norwood has control over a total of 27,304 shares of the company, with 27,304 shares held directly. SEC Filing:...